Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|3|285-295

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.3, 2011-03, pp. : 285-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 517-536

Bentham Science Publishers

Access to resources Recommend Favorite

Second-generation kinase inhibitors

By Klebl Bert M   Müller Gerhard  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 975-993

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Immunoproteasome: Current Status and Future Directions

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4140-4151

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Second Generation HIV-1 Integrase Inhibitors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Second Generation Phosphodiesterase 5 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-01 ,pp. : 405-419

Bentham Science Publishers

Access to resources Recommend Favorite